Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, Roy S, Soria, Jean-Charles, Kowanetz, Marcin, Fine, Gregg D, Hamid, Omid, Gordon, Michael S, Sosman, Jeffery A, McDermott, David F, Powderly, John D, Gettinger, Scott N, Kohrt, Holbrook E K, Horn, Leora, Lawrence, Donald P, Rost, Sandra, Leabman, Maya, Xiao, Yuanyuan, Mokatrin, Ahmad, Koeppen, Hartmut, Hegde, Priti S, Mellman, Ira, Chen, Daniel S, Hodi, F Stephen
Published in Nature (London) (27.11.2014)
Published in Nature (London) (27.11.2014)
Get full text
Journal Article
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
McDermott, David F, Sosman, Jeffrey A, Sznol, Mario, Massard, Christophe, Gordon, Michael S, Hamid, Omid, Powderly, John D, Infante, Jeffrey R, Fassò, Marcella, Wang, Yan V, Zou, Wei, Hegde, Priti S, Fine, Gregg D, Powles, Thomas
Published in Journal of clinical oncology (10.03.2016)
Published in Journal of clinical oncology (10.03.2016)
Get full text
Journal Article
Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 Study
Gettinger, Scott, Horn, Leora, Jackman, David, Spigel, David, Antonia, Scott, Hellmann, Matthew, Powderly, John, Heist, Rebecca, Sequist, Lecia V, Smith, David C, Leming, Philip, Geese, William J, Yoon, Dennis, Li, Ang, Brahmer, Julie
Published in Journal of clinical oncology (10.06.2018)
Published in Journal of clinical oncology (10.06.2018)
Get full text
Journal Article
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
TOPALIAN, Suzanne L, SZNOL, Mario, LEMING, Philip D, LIPSON, Evan J, PUZANOV, Igor, SMITH, David C, TAUBE, Janis M, WIGGINTON, Jon M, KOLLIA, Georgia D, GUPTA, Ashok, PARDOLL, Drew M, SOSMAN, Jeffrey A, McDERMOTT, David F, STEPHEN HODI, F, KLUGER, Harriet M, CARVAJAL, Richard D, SHARFMAN, William H, BRAHMER, Julie R, LAWRENCE, Donald P, ATKINS, Michael B, POWDERLY, John D
Published in Journal of clinical oncology (01.04.2014)
Published in Journal of clinical oncology (01.04.2014)
Get full text
Journal Article
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
BRAHMER, Julie R, DRAKE, Charles G, GILSON, Marta M, CHANGYU WANG, SELBY, Mark, TAUBE, Janis M, ANDERS, Robert, LIEPING CHEN, KORMAN, Alan J, PARDOLL, Drew M, LOWY, Israel, TOPALIAN, Suzanne L, WOLLNER, Ira, POWDERLY, John D, PICUS, Joel, SHARFMAN, William H, STANKEVICH, Elizabeth, PONS, Alice, SALAY, Theresa M, MCMILLER, Tracee L
Published in Journal of clinical oncology (01.07.2010)
Published in Journal of clinical oncology (01.07.2010)
Get full text
Journal Article
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Gettinger, Scott N, Horn, Leora, Gandhi, Leena, Spigel, David R, Antonia, Scott J, Rizvi, Naiyer A, Powderly, John D, Heist, Rebecca S, Carvajal, Richard D, Jackman, David M, Sequist, Lecia V, Smith, David C, Leming, Philip, Carbone, David P, Pinder-Schenck, Mary C, Topalian, Suzanne L, Hodi, F Stephen, Sosman, Jeffrey A, Sznol, Mario, McDermott, David F, Pardoll, Drew M, Sankar, Vindira, Ahlers, Christoph M, Salvati, Mark, Wigginton, Jon M, Hellmann, Matthew D, Kollia, Georgia D, Gupta, Ashok K, Brahmer, Julie R
Published in Journal of clinical oncology (20.06.2015)
Published in Journal of clinical oncology (20.06.2015)
Get full text
Journal Article
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab
McDermott, David F, Drake, Charles G, Sznol, Mario, Choueiri, Toni K, Powderly, John D, Smith, David C, Brahmer, Julie R, Carvajal, Richard D, Hammers, Hans J, Puzanov, Igor, Hodi, F Stephen, Kluger, Harriet M, Topalian, Suzanne L, Pardoll, Drew M, Wigginton, Jon M, Kollia, Georgia D, Gupta, Ashok, McDonald, Dan, Sankar, Vindira, Sosman, Jeffrey A, Atkins, Michael B
Published in Journal of clinical oncology (20.06.2015)
Published in Journal of clinical oncology (20.06.2015)
Get full text
Journal Article
Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab
Topalian, Suzanne L, Hodi, F Stephen, Brahmer, Julie R, Gettinger, Scott N, Smith, David C, McDermott, David F, Powderly, John D, Sosman, Jeffrey A, Atkins, Michael B, Leming, Philip D, Spigel, David R, Antonia, Scott J, Drilon, Alexander, Wolchok, Jedd D, Carvajal, Richard D, McHenry, M Brent, Hosein, Fareeda, Harbison, Christopher T, Grosso, Joseph F, Sznol, Mario
Published in JAMA oncology (01.10.2019)
Published in JAMA oncology (01.10.2019)
Get more information
Journal Article
Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
WEBER, Jeffrey S, O'DAY, Steven, URBA, Walter, POWDERLY, John, NICHOL, Geoff, YELLIN, Michael, SNIVELY, Jolie, HERSH, Evan
Published in Journal of clinical oncology (20.12.2008)
Published in Journal of clinical oncology (20.12.2008)
Get full text
Journal Article
First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors
Demetri, George D, Luke, Jason J, Hollebecque, Antoine, Powderly, 2nd, John D, Spira, Alexander I, Subbiah, Vivek, Naumovski, Louie, Chen, Chris, Fang, Hua, Lai, Dominic W, Yue, Huibin, Polepally, Akshanth R, Purcell, James W, Robinson, Randy, Sharma, Padmanee, Allison, James P, Tolcher, Anthony, Villalobos, Victor M
Published in Clinical cancer research (01.07.2021)
Published in Clinical cancer research (01.07.2021)
Get full text
Journal Article
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab
Hamid, Omid, Molinero, Luciana, Bolen, Christopher R, Sosman, Jeffrey A, Muñoz-Couselo, Eva, Kluger, Harriet M, McDermott, David F, Powderly, John D, Sarkar, Indrani, Ballinger, Marcus, Fassò, Marcella, O'Hear, Carol, Chen, Daniel S, Hegde, Priti S, Hodi, F Stephen
Published in Clinical cancer research (15.10.2019)
Published in Clinical cancer research (15.10.2019)
Get full text
Journal Article
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Brahmer, Julie R, Drake, Charles G, Wollner, Ira, Powderly, John D, Picus, Joel, Sharfman, William H, Stankevich, Elizabeth, Pons, Alice, Salay, Theresa M, McMiller, Tracee L, Gilson, Marta M, Wang, Changyu, Selby, Mark, Taube, Janis M, Anders, Robert, Chen, Lieping, Korman, Alan J, Pardoll, Drew M, Lowy, Israel, Topalian, Suzanne L
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial
Hassan, Raffit, Thomas, Anish, Nemunaitis, John J, Patel, Manish R, Bennouna, Jaafar, Chen, Franklin L, Delord, Jean-Pierre, Dowlati, Afshin, Kochuparambil, Samith T, Taylor, Matthew H, Powderly, John D, Vaishampayan, Ulka N, Verschraegen, Claire, Grote, Hans Juergen, von Heydebreck, Anja, Chin, Kevin, Gulley, James L
Published in JAMA oncology (01.03.2019)
Published in JAMA oncology (01.03.2019)
Get more information
Journal Article
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study
Powderly, John D, Klempner, Samuel J, Naing, Aung, Bendell, Johanna, Garrido-Laguna, Ignacio, Catenacci, Daniel V T, Taylor, Matthew H, Lee, James J, Zheng, Fred, Zhou, Feng, Gong, Xiaohua, Gowda, Hema, Beatty, Gregory L
Published in The oncologist (Dayton, Ohio) (03.11.2022)
Published in The oncologist (Dayton, Ohio) (03.11.2022)
Get full text
Journal Article
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Topalian, Suzanne L, Sznol, Mario, McDermott, David F, Kluger, Harriet M, Carvajal, Richard D, Sharfman, William H, Brahmer, Julie R, Lawrence, Donald P, Atkins, Michael B, Powderly, John D, Leming, Philip D, Lipson, Evan J, Puzanov, Igor, Smith, David C, Taube, Janis M, Wigginton, Jon M, Kollia, Georgia D, Gupta, Ashok, Pardoll, Drew M, Sosman, Jeffrey A, Hodi, F Stephen
Published in Journal of clinical oncology (10.02.2023)
Published in Journal of clinical oncology (10.02.2023)
Get full text
Journal Article
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1–Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial
Garon, Edward B., Spira, Alexander I., Goldberg, Sarah B., Chaft, Jamie E., Papadimitrakopoulou, Vassiliki, Cascone, Tina, Antonia, Scott J., Brahmer, Julie R., Camidge, D. Ross, Powderly, John D., Wozniak, Antoinette J., Felip, Enriqueta, Wu, Song, Ascierto, Maria L., Elgeioushi, Nairouz, Awad, Mark M.
Published in Journal of thoracic oncology (01.08.2023)
Published in Journal of thoracic oncology (01.08.2023)
Get full text
Journal Article
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study
Naing, Aung, Powderly, John D, Nemunaitis, John J, Luke, Jason J, Mansfield, Aaron S, Messersmith, Wells A, Sahebjam, Solmaz, LoRusso, Patricia M, Garrido-Laguna, Ignacio, Leopold, Lance, Geschwindt, Ryan, Ding, Kai, Smith, Michael, Berlin, Jordan D
Published in Journal for immunotherapy of cancer (01.03.2022)
Published in Journal for immunotherapy of cancer (01.03.2022)
Get full text
Journal Article
Differential drug responses of circulating tumor cells within patient blood
Hughes, Andrew D, Marshall, Jocelyn R, Keller, Eric, Powderly, John D, Greene, Bryan T, King, Michael R
Published in Cancer letters (28.09.2014)
Published in Cancer letters (28.09.2014)
Get full text
Journal Article